A nationally recognized leader in academic medicine, Mary E. Klotman, MD, is executive vice president for health affairs at Duke University, dean of the Duke University School of Medicine, and chief academic officer for Duke Health.

Klotman was appointed as Duke’s first executive vice president for health affairs in June 2023 and assumed her new role on July 1, 2023. She was named dean of the School of Medicine in January 2017 and was appointed to a second five-year term in 2022. Prior to her appointment as dean, Klotman served with distinction as chair of the Department of Medicine in the Duke University School of Medicine for seven years.

Klotman earned her undergraduate and medical degrees from Duke University. She completed her internal medicine residency and a fellowship in Infectious Diseases in the Department of Medicine at Duke before joining the faculty as assistant professor of medicine. She joined the National Institutes of Health in 1991, where she was a member of the Public Health Service and trained and worked in the Laboratory of Tumor Cell Biology under the direction of Robert C. Gallo, MD.

Before returning to Duke in 2010, Klotman joined Mount Sinai School of Medicine where she was the Irene and Dr. Arthur M. Fishberg Professor of Medicine and served as chief of the Division of Infectious Diseases for 13 years. She was also co-director of Mount Sinai’s Global Health and Emerging Pathogens Institute, a program designed to translate basic science discoveries into clinical therapeutics for newly emerging and re-emerging infectious diseases. 

A pioneering physician-scientist, Klotman’s research interests are focused on the molecular pathogenesis of Human Immunodeficiency Virus 1 (HIV-1) infection. Among many important contributions to this field, Klotman and her team demonstrated that HIV resides in and evolves separately in kidney cells, a critical step in HIV-associated kidney disease. Most recently, her group has been defining the role of integrase-defective lentiviral vectors for the delivery of an HIV vaccine.

Klotman is a councilor of the Association of American Physicians and past president of the Association of Professors of Medicine. She was elected to membership in the Academy of Medicine in 2014. Klotman is a former president of the Duke Medical Alumni Association and received a Duke University School of Medicine Distinguished Alumni Award in 2015.

Leigh Bleecker, MBA, MHA, is the Assistant Vice President for Finance and Chief Financial Officer for Duke Raleigh Hospital, a Campus of Duke University Hospital and Duke Regional Hospital. She has been a part of the Duke Health Finance team since 2002. Leigh has also had the privilege of serving as Interim President of Duke Raleigh Hospital on two occasions.

Prior to joining Duke Health, Bleecker worked as a financial consultant with OSI Systems in Atlanta, Georgia.  She is a native of North Carolina, originally from Fayetteville.

She received her bachelor’s degree in chemistry from the University of North Carolina at Chapel Hill and her MBA and MHA from Georgia State University.

In 2007, Bleecker received the Triangle Business Journal’s 40 under 40 award and was named CFO of the Year in 2012.

She is active in community outreach and serves on several community boards, including current board member of Urban Ministries of Wake County, member of Holt Brothers Foundation, former treasurer and board chair of InterAct of Wake County, and former NC Commissioner of Tryon Palace. Bleecker began volunteering in 2001 as a camp counselor for Camp Sunshine, a summer camp for children with cancer and still serves in that role today.

Lori Pickens, is the Associate Vice President, Oncology Services for Duke University Health System, as well as Administrator and Associate Dean, Duke Cancer Institute, Duke University School of Medicine.Previously she served as Assistant Vice President, Clinical Programs, Duke Cancer Institute. Pickens joined Duke in 2007, serving as Director of the Duke Raleigh Cancer Center and in 2009 was named Administrative Director for the Preston Robert Tisch Brain Tumor Center.Before coming to Duke, she served as CEO of the American Lung Association of Missouri. Pickens also served as a director for a health plan operated by BJC Health System and Washington University School of Medicine in St. Louis.Prior to her transition into health care, Pickens spent more than 12 years working in corporate America in a variety of management capacities. She received her bachelor’s degree in business administration from Clark University in Worcester, Massachusetts, and her MHA from Washington University School of Medicine in St. Louis, Missouri, followed by an administrative fellowship at Henry Ford Health System in Detroit, Michigan.

Michael Kastan, MD, PhD, is the Executive Director of the Duke Cancer Institute and William and Jane Shingleton Professor of Pharmacology and Cancer Biology.

As a pediatric oncologist and a cancer biologist, Kastan conducts laboratory research concentrated on DNA damage and repair, tumor suppressor genes, and causes of cancer related to genetic predisposition and environmental exposures. His discoveries have made a major impact on our understanding of both how cancers develop and how they respond to chemotherapy and radiation therapy, and his publications reporting the roles of p53 and ATM in DNA damage signaling are among the most highly cited publications in the biomedical literature of the past 25 years. He has received numerous honors for his highly cited work, including election to the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts & Sciences, as well as receipt of the AACR-G.H.A. Clowes Memorial Award for outstanding contributions to basic cancer research. He has served as Chairman of the Board of Scientific Counselors of the National Cancer Institute, on the Boards of Directors of the American Association for Cancer Research (AACR) and the American Association of Cancer Institutes (AACI), as editor-in-chief of the journal Molecular Cancer Research, and as editor of the textbook Clinical Oncology.

Kastan earned his degrees from the Washington University School of Medicine and did his clinical training in Pediatrics and Pediatric Hematology-Oncology at Johns Hopkins University. Before moving to Duke in 2011, Kastan was a Professor of Oncology, Pediatrics and Molecular Biology at Johns Hopkins University and Chair of the Hematology-Oncology department, as well as the Cancer Center Director at St. Jude Children's Research Hospital. 

Paul Lindia is Vice President for Network Services at Duke University Health System (DUHS) and has been a part of the Duke University Health System for more than 27 years. Lindia oversees Duke University Health System’s clinical affiliations with community hospitals as well as the Duke LifePoint Healthcare relationship.

Prior to assuming his current role in 2001, Lindia served as chief operating officer at Duke Raleigh Hospital. He directed hospital operations and a staff of more than 800 FTEs, with an annual budget in excess of $100 million.

Lindia also served as DUHS Senior Director, Hospitals’ Operations Integration where he led the organization through restructuring initiatives including system-wide alignment of various operational departments. He led efforts to integrate major clinical and departmental systems and programs across the health system using business plans and business case reports to support the integration projects.

Lindia has also served as Assistant Chief Operating Officer for Surgical and Professional Services at Duke University Hospital. He was responsible for leading operational efforts in all areas of surgical and peri-operative services along with traditional hospital non-clinical departments.

Lindia is a graduate of Yale University and received a Master’s of Public Health in healthcare administration. He received his bachelor of science degree in business administration/accounting from Central Connecticut State University.

Kevin W. Sowers, MSN, RN, FAAN, is the President of Duke University Hospital. Sowers joined Duke University Hospital in 1985 as a staff nurse in oncology and has been in leadership roles within Duke University Health System over the last 20 years.Prior to becoming president, Sowers served as the Chief Operating Officer for Duke University Hospital from 2003 to 2009. He received his BSN from Capital University in Columbus, Ohio and his MSN from Duke University School of Nursing. Sowers is accountable for the operations of the 957-bed academic teaching hospital with over 10,000 faculty, staff and volunteers. He is responsible for driving organizational excellence and implementing the strategic plan of the organization in collaboration with the Duke Health physician group. Sowers is internationally known for his lectures and writings on the issues of leadership, organizational change, mentorship and cancer care. He is currently on the Board of Directors for University Healthcare Consortium and the Counsel of Teaching Hospitals. He is adjunct faculty at Duke University School of Nursing, Duke University Fuqua School of Business and UNC School of Public Health. He has also served in leadership roles with the American Heart Association, Susan G. Komen and a variety of leadership roles at the national level within the Oncology Nursing Society.  

Shilpa Shelton, MHA, FACHE, is Associate Vice President for Musculoskeletal & Spine Services at Duke University Health System.

Prior to this role, Shelton was the vice president for Duke University Hospital and provided senior administrative oversight for neuroscience and orthopedic clinical services, including procedural and diagnostic services such as neurodiagnostic services, pain services, and physical therapy and occupational therapy services. In addition, she oversees hospital-based outpatient clinics for orthopaedic trauma, spine and pain services.

Prior to being appointed to vice president, Shelton served as senior strategic services associate and led strategic planning efforts for the integration of the newly formed Duke University Health System. In prior roles, she spearheaded operations improvement initiatives and breakthrough clinical quality improvement. In addition, she has successfully led several financial turn-around initiatives, as well as hospital-wide physician satisfaction initiatives.

She received her undergraduate degree in biology from Wheaton College in Norton, Massachusetts and her master’s in health care administration from Duke University’s Fuqua School of Business. Shelton completed her Administrative Fellowship at Mercy Health System in Michigan.

Shelton is a Fellow of the American College of Health Care Executives and served on its National Chapter Leaders Committee. She is Past President of the Triangle Healthcare Executive Forum. Shelton also served as an adjunct faculty member for Pfeiffer University’s MHA/MBA program teaching Healthcare Finance. She is often a speaker at Fuqua School of Business’ Health Sector Management Program, as well as orthopedic conferences across the country.

Trudy Sullivan Stoudamire is the Senior Vice President and Chief Marketing and Communications Officer at Duke University Health System. In her role, Sullivan Stoudamire leads an integrated marketing and communications strategy, focusing on reputation management, brand-enhancement, digital innovation, and stakeholder engagement. She plays a critical role in aligning DUHS’s strategic priorities with innovative marketing approaches, ensuring that our message reaches patients, providers, team members, and the broader community.

Prior to this role, Sullivan Stoudamire held executive leadership roles at Health Catalyst, Raytheon, Micron Technology, and the American Red Cross, demonstrating her ability to build high-performing teams, execute strategic marketing initiatives, and elevate organizational presence in competitive landscapes. With an impressive background spanning healthcare, technology, and defense industries, Trudy has a proven track record of enhancing brand equity, leading transformative communication strategies, and driving measurable business growth.

Sullivan Stoudamire earned her Bachelor of Arts from the University of Portland and her Master of Business Administration from Kellogg Graduate School of Management, Northwestern University. She is very active in her community, serving on a number of boards focused on advancing education, healthcare and inclusion.